SHIP2-PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma.

Auteurs

Ramos AR, Bregni G, Gillet N, Ando K, Bodart C, Vercauteren Drubbel A, Descampe L, Moresi F, Bisteau X, Verheye Q, Pirard S, Erneux C, Beck B

  • Date de publication

    November 2025

  • Type

    Article

  • Review

    Mol Cancer

  • Researcher's name

    BREGNI GIACOMO

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique

  • PMID

    41188852

  • DOI

    10.1186/s12943-025-02454-z